Skip to main content
Equibles

GOLDMAN SACHS GROUP INC

Position in ACHV — Achieve Life Sciences, Inc.

CIK 886982 NEW YORK, NY
Back to ACHV Full portfolio

Position in ACHV

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$267,573
-$182,105 QoQ
Shares Held
40,976
-73.2% QoQ
Ownership
0.040%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#59
of 111 holders
Holding Since
Dec 2020
11 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in ACHV Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

GOLDMAN SACHS GROUP INC holds $13,181,249,908 across 360 Biotechnology names. ACHV ranks #309 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 VRTX
Vertex Pharmaceuticals Inc / Ma
 2,481,761 $1,232,765,138
2 REGN
Regeneron Pharmaceuticals, Inc.
 1,163,191 $725,296,113
3 ROIV
Roivant Sciences Ltd.
 18,556,458 $656,713,046
4 TECH
BIO-TECHNE Corp
 7,343,324 $518,805,838
5 RVMD
Revolution Medicines, Inc.
 2,133,101 $399,487,154
6 MRNA
Moderna, Inc.
 4,671,950 $327,176,656
7 TNGX
Tango Therapeutics, Inc.
 9,980,620 $311,994,180
8 INCY
Incyte Corp
 2,305,782 $261,383,446

All Filings in ACHV

Export CSV
11 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $267,573 40,976
2026-03-31 $449,678 152,952
2025-12-31 $2,241,112 450,928
2025-09-30 $705,073 223,833
2025-06-30 $135,407 59,915
2025-03-31 $294,623 110,346
2024-12-31 $532,136 151,175
2024-09-30 $1,113,260 234,865
2024-06-30 $162,328 34,538
2024-03-31 $101,091 22,218
2020-12-31 $87,609 10,816